cardiology-summit-2019-scientifictracks

Page 46

March 25-26, 2019 | Amsterdam, Netherlands

CARDIOLOGY

AND CARDIAC NURSING

World Congress on

Cardiology Summit 2019

Journal of Cardiovascular Medicine and Therapeutics | Volume 3

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

YEARS

Note:

PRESTO SCORE: SIMPLE SCORE FOR EARLY DISCHARGE OF PATIENTS

WITH ST-ELEVATION MYOCARDIAL INFARCTION TREATEDWITH PRIMARY

PERCUTANEOUS CORONARY ANGIOPLASTY

Alejandro Avila Carrillo

University clinical hospital of santiago, Spain

Background:

Early Discharge (ED) for low-risk patients treated with primary coronary angioplasty is safe and

cost-effective. Scoring systems for ED are sophisticated and time-consuming for daily use.

Methods:

We developed a score to identify low-risk patients suitables for ED; 10 points was the cutoff. Sensibility

and specificity was calculated. A survival analysis was performed comparing the results versus the GRACE score.

Results:

Based on the PRESTO score we classified 1723 patients, 43.23%were in the low-risk group (<10) getting

a less cumulative incidence of major adverse cardiovascular events (MACE) and all-cause death than patients

with high-risk (≥10). The estimated hazard ratio for MACE was (HR) 11, 73 (95% confidence interval [95% CI]

3.64-37.77, p = <0.001) and for all-cause death HR 36, 77 (95% CI 5.07-266.67, p = <0.001) in the low-risk group

at 7 days of follow-up. PRESTO score got a sensitivity (SE) of 90.2% and a specificity (SP) of 45.9% for predicting

MACE with an area under ROC curve (AUC) of 0.68. The AUC for predicting all-cause death was 0.71 (SE of 98.0%

and SP of 45.7%). There were significant differences in favor to our score for predicting all-cause death (p = 0.005

to 7 days, p = <0.001 to 30 days, p = <0.001 to 90 days) and without difference for predicting MACE.

Conclusions:

The PRESTO score is a simple and accurate tool for identifying low-risk patients for early discharge

after primary angioplasty, with a better prediction of all-cause death compared to the GRACE score.

Alejandro Avila Carrillo, J Cardiovasc Med Ther 2019, Volume 3

Alejandro Avila Carrillo completed his medical degree at the age of 24 years from University of Guadalajara, Mexico.

After he completed his cardiology fellowship at Hospital de Especialidades “Antonio Fraga Mouret”, Mexico City, then

completed his interventional cardiology fellowship at Hospital Clínico de Santiago de Compostela, in this fellowship he

performed a clinical and basic investigation, involving interventional cardiology and biomaterials in interventional cardi-

ology, even wining a grant to develop a newmaterial for bioabsorbible coronary stent (today ongoing), also participated

in a clinical proyect of clinical 3d printing, publishing a paper at revista Española de cardiología. Today he is attending

physician at cardiology staff of Hospital de Especialidades “Antonio Fraga Mouret”, Mexico City and combine this with

private medical activity.

BIOGRAPHY